🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Novanta Inc. NOVT R2K

Technology · Scientific & Technical Instruments · United States
https://www.novanta.com

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

READ MORE ›
$159.33
+28.68% 1Y

Market & Price

Market Cap
$5.67B
Current Price
$159.33
High / Low (52W)
$163.29 / $99.22
Beta
1.62

Valuation

Stock P/E
114.63
Industry PE
32.74
Forward P/E
38.45
PEG Ratio
-
Book Value
$36.81
Price to Book
4.33
P/S
5.65
EV/EBITDA
31.19
Dividend Yield
-

Profitability & Returns

ROCE
7.32%
ROE
5.16%
ROA
4.56%
Profit Margin
5.35%
Op Margin
11.70%
EPS (Latest Qtr)
$0.51
EPS (TTM)
$1.39

Balance Sheet & Liquidity

Debt/Equity
0.22
Quick Ratio
2.55
Current Ratio
3.56
Debt
$291.34M
Total Assets
$1.81B
Current Assets
$782.60M
Working Capital
$570.23M

Ownership

Promoter Holding
0.79%
Chg in Prom Hold
-
FII / Inst Holding
119.38%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
$5.58B
Total Revenue (TTM)
$1.00B
EBITDA
$178.81M
Free Cash Flow
$87.25M
Operating Cash Flow
$83.98M
Shares Outstanding
35.61M
Gross Margin
44.23%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
4.43%
Profit 5Y
-10.09%
Revenue (YoY)
10.40%
Earnings (YoY)
-13.40%

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 114.6.
  • Earnings shrank at -10.1% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Technology).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NOVT Novanta Inc. R2K 159.33 114.63 $5.67B - 7.32% 5.16% 4.43% -10.09%
2 NVDA NVIDIA Corporation NDXSPXAI 211.14 32.38 $5.11T 0.47% 81.14% 114.29% 100.05% 201.80%
3 AAPL Apple Inc. NDXSPX 312.06 37.73 $4.58T 0.35% 68.72% 141.47% 1.81% 3.92%
4 MSFT Microsoft Corporation NDXSPXAI 450.24 26.82 $3.34T 0.81% 26.37% 34.01% 12.42% 11.87%
5 TSM Taiwan Semiconductor Manufacturing Company Limited AI 418.45 35.86 $2.17T 0.91% 32.04% 36.21% 18.94% 19.57%
6 MU Micron Technology, Inc. NDXSPXAI 971.00 45.87 $1.10T 0.06% 14.20% 39.82% 6.71% -0.57%
7 AMD Advanced Micro Devices, Inc. NDXSPXAI 516.10 172.61 $841.55B - 6.33% 8.06% 13.64% 48.64%
8 ORCL Oracle Corporation SPXAI 225.78 40.46 $649.35B 0.89% 13.07% 57.57% 10.59% 22.81%
9 ASML ASML Holding N.V. NDXAI 1,612.76 53.76 $621.59B 0.54% 43.81% 52.24% 15.55% 19.55%
Ad space

Quarterly Results

Figures in USD.

Metric Jun 2014Sep 2014Dec 2014Apr 2015Jul 2015Oct 2015Dec 2015Apr 2016Jul 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Apr 2020Jul 2020Oct 2020Apr 2021Jul 2021Oct 2021Apr 2022Jul 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Apr 2026
Revenue -----------119.10M146.30M146.97M150.40M160.79M157.19M155.15M154.07M155.47M144.73M142.93M162.58M167.52M177.73M204.22M215.36M222.96M219.13M229.46M221.50M230.92M235.86M244.41M233.37M241.05M247.84M258.35M257.71M257.71M
Cost of Revenue ----------------------------------129.01M134.30M136.91M145.09M144.13M-
Gross Profit 38.65M39.68M39.73M40.01M41.34M39.91M36.63M36.89M41.50M41.21M46.09M53.49M58.71M62.16M65.23M69.63M66.29M65.78M64.05M64.44M58.70M59.10M68.74M72.41M76.30M90.28M95.25M98.41M97.63M104.12M101.59M100.42M103.69M109.22M104.35M106.75M110.92M113.26M113.58M113.58M
Operating Expenses ----------------------------------74.39M79.26M82.40M82.57M83.43M-
Operating Income 6.48M6.82M-34.18M5.40M10.31M9.01M4.21M2.59M7.60M11.05M10.34M15.75M12.41M17.23M17.11M21.00M14.39M15.11M12.80M13.25M13.70M11.87M11.10M15.99M15.28M24.28M23.29M28.66M26.31M32.20M30.31M25.61M25.71M32.55M29.97M27.48M28.52M30.69M30.14M27.54M
EBITDA ----------------------------------43.53M43.06M44.24M47.77M44.30M-
Interest Expense ----------------------------------------
Pretax Income ----------------------------------26.42M5.79M15.76M21.68M26.35M-
Tax Provision ----------------------------------5.21M1.29M5.11M4.21M5.25M-
Net Income 725.00K4.53M-30.48M3.45M19.50M6.57M-1.91M4.87M7.47M34.25M9.40M7.53M11.91M11.00M14.55M12.25M10.38M8.92M11.95M11.66M8.26M11.31M11.66M13.60M18.82M17.48M22.49M18.27M20.88M21.22M14.68M13.76M19.19M21.21M4.50M10.65M17.47M21.10M21.10M
Diluted EPS 0.020.13-0.880.100.560.190.180.050.140.210.980.160.000.180.320.600.350.290.250.340.330.230.320.330.380.530.490.630.510.580.590.410.380.530.590.120.300.450.510.51
R&D Expense 7.53M7.74M7.84M8.21M7.84M7.69M7.29M8.05M8.02M7.96M9.21M9.00M11.66M11.99M12.55M13.20M14.00M13.39M13.81M15.33M14.44M15.23M18.68M16.95M17.47M20.93M21.59M21.35M22.83M23.38M22.02M23.25M23.73M23.25M23.24M25.29M24.09M--23.25M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------384.76M521.29M614.34M626.10M590.62M706.79M860.90M881.66M949.25M980.60M
Cost of Revenue -------------482.43M481.76M527.70M545.32M
Gross Profit 98.55M130.61M133.10M105.52M132.23M150.17M157.89M162.45M220.53M261.53M262.08M244.52M300.33M378.47M399.90M421.55M435.28M
Operating Expenses -------------271.01M276.59M297.25M318.62M
Operating Income -20.24M36.03M35.85M20.26M19.45M-16.81M28.93M32.95M57.57M71.01M55.28M55.89M64.05M107.46M123.31M124.29M116.66M
EBITDA -------------160.62M169.92M179.86M178.60M
Interest Expense -----------------
Pretax Income -------------87.16M83.75M79.07M69.64M
Tax Provision -------------13.11M10.87M14.98M15.81M
Net Income -71.33M-687.00K28.97M19.54M7.31M-24.25M35.62M22.00M60.05M49.11M40.77M44.52M50.33M74.05M72.88M64.09M53.83M
Diluted EPS -4.48-0.030.860.580.21-0.701.020.631.131.431.151.251.412.062.021.771.47
R&D Expense 28.25M22.30M23.45M18.53M23.79M28.95M31.04M32.00M41.67M51.02M55.97M61.00M72.52M85.77M91.68M95.52M95.48M

Compounded Sales Growth

5 Years:4.43%
1 Year:10.40%

Compounded Profit Growth

5 Years:-10.09%
1 Year:-13.40%

Stock Price Performance

1 Year:+28.68%
6 Months:+42.40%
3 Months:+18.52%
1 Month:+31.80%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --367.17M348.50M337.46M378.81M396.29M416.05M425.64M726.70M719.58M869.74M865.18M-1.24B1.23B1.39B1.81B
Current Assets --------------420.52M415.30M433.65M782.60M
Cash & Equivalents 69.00M63.33M56.78M54.84M65.79M60.98M51.15M59.96M68.11M100.06M82.04M78.94M125.05M-100.11M105.05M113.99M380.87M
Inventory --------------168.00M149.37M144.61M188.28M
Receivables --------------137.70M139.41M151.03M184.88M
Total Liabilities --188.49M139.14M109.25M136.40M185.04M171.34M166.77M368.24M351.32M452.56M388.37M-663.63M552.60M642.81M492.82M
Current Liabilities --59.26M59.06M54.93M61.49M54.06M56.95M70.50M98.17M104.20M134.85M114.23M-164.52M139.18M167.79M212.37M
Long Term Debt --107.58M58.00M42.50M64.00M105.03M88.43M70.55M225.50M202.84M215.33M194.93M-430.66M349.40M411.95M212.54M
Total Debt --------------489.38M404.56M470.24M301.91M
Total Equity --178.35M209.00M227.81M241.98M210.82M244.70M258.87M311.55M368.25M417.17M476.81M-577.59M673.46M745.70M1.31B
Shares Outstanding --------------35.71M35.81M35.94M35.67M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -25.79M-4.74M45.17M28.43M49.20M42.29M33.42M47.79M63.38M89.65M63.25M140.24M-90.78M120.08M158.51M64.06M
Investing Cash Flow 19.71M8.75M-4.22M2.98M-72.96M-89.77M-1.63M-12.87M-177.38M-45.59M-63.84M-13.16M--42.54M-19.89M-208.19M-74.32M
Financing Cash Flow --11.56M-43.09M-21.11M18.57M40.28M-21.54M-23.19M143.33M-60.16M-3.94M-84.36M--60.15M-97.85M56.94M276.33M
Capital Expenditure -1.32M-2.66M-4.22M-3.52M-4.78M-5.42M-5.55M-8.46M-9.09M-14.66M-10.74M-10.52M--21.11M-19.96M-17.16M-15.63M
Free Cash Flow -27.11M-7.40M40.96M24.91M44.42M36.87M27.86M39.33M54.28M74.99M52.51M129.72M-69.67M100.11M141.35M48.43M
Net Change in Cash --------------11.92M2.33M7.27M266.06M
Share Buybacks ----526.00K-1.63M1.63M370.00K5.85M10.00M5.50M-10.00M--39.28M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------42.2%42.3%42.6%41.9%41.4%42.5%44.0%45.4%44.4%44.4%
Operating Margin % -------8.6%11.0%11.6%8.8%9.5%9.1%12.5%14.0%13.1%11.9%
Net Margin % -------5.7%11.5%8.0%6.5%7.5%7.1%8.6%8.3%6.8%5.5%
ROE % --0.4%13.9%8.6%3.0%-11.5%14.6%8.5%19.3%13.3%9.8%9.3%-12.8%10.8%8.6%4.1%
ROCE % -11.7%12.4%7.2%6.1%-4.9%8.1%9.3%9.2%11.5%7.5%7.4%-10.0%11.3%10.2%7.3%

Shareholding Pattern

Insiders
0.79%
Institutions
119.38%
Public Float
120.33%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 13.07% 4.65M $741.66M
2 Vanguard Portfolio Management LLC 6.96% 2.48M $394.64M
3 Price (T.Rowe) Associates Inc 5.01% 1.78M $284.31M
4 Allspring Global Investments Holdings, LLC 4.99% 1.78M $283.08M
5 Vanguard Capital Management LLC 4.53% 1.61M $257.03M
6 Conestoga Capital Advisors, LLC 4.07% 1.45M $231.00M
7 State Street Corporation 3.76% 1.34M $213.37M
8 Wasatch Advisors LP 2.80% 996.64K $158.80M
9 Geode Capital Management, LLC 2.63% 936.97K $149.29M
10 Geneva Capital Management LLC 2.62% 931.27K $148.38M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NOVT

No recent headlines available.

Explore More

📊 Technology Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks